Trial Profile
Multiple ascending dose trial of AVI 6002 in volunteers.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 11 Feb 2012
Price :
$35
*
At a glance
- Drugs AVI 6002 (Primary)
- Indications Ebola virus infections
- Focus Adverse reactions; Pharmacokinetics
- 11 Feb 2012 New trial record